KATIE BARNES: Open Payments
NPI 1023046794 · FAIRVIEW, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 59 payments from 18 companies in 2025. Trend: 2023 $1,405 · 2024 $1,329 · 2025 $1,347
Food & beverage: $1,347
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $382 |
| ABBVIE INC. | 5 | $141 |
| PFIZER INC. | 6 | $137 |
| Lilly USA, LLC | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Exact Sciences Corporation | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: Ozempic, Rybelsus, Wegovy, QULIPTA, Cologuard Collection Kit, PREVNAR 20, GVOKE HYPOPEN, Kerendia.
Industry payments across TN — which companies pay providers there.
